KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Teladoc Health (TDOC) Amortization - Intangibles (2023 - 2026)

Teladoc Health's Amortization - Intangibles history spans 4 years, with the latest figure at $89.8 million for Q1 2026.

  • On a quarterly basis, Amortization - Intangibles rose 6.55% to $89.8 million in Q1 2026 year-over-year; TTM through Mar 2026 was $356.3 million, a 1.04% increase, with the full-year FY2025 number at $350.8 million, down 3.47% from a year prior.
  • Amortization - Intangibles hit $89.8 million in Q1 2026 for Teladoc Health, down from $92.0 million in the prior quarter.
  • Over the last five years, Amortization - Intangibles for TDOC hit a ceiling of $95.1 million in Q1 2024 and a floor of $66.9 million in Q1 2023.
  • Historically, Amortization - Intangibles has averaged $86.9 million across 4 years, with a median of $88.7 million in 2025.
  • Biggest five-year swings in Amortization - Intangibles: soared 42.17% in 2024 and later fell 11.31% in 2025.
  • Tracing TDOC's Amortization - Intangibles over 4 years: stood at $94.7 million in 2023, then dropped by 8.64% to $86.5 million in 2024, then increased by 6.35% to $92.0 million in 2025, then fell by 2.4% to $89.8 million in 2026.
  • Business Quant data shows Amortization - Intangibles for TDOC at $89.8 million in Q1 2026, $92.0 million in Q4 2025, and $85.8 million in Q3 2025.